Product |
Molecular Structure |
Cas No. |
Usages |
Levodopa |
59-92-7 |
API |
|
NMN |
1094-61-7 |
Dietary supplement |
|
L-2-Aminobutanamide |
7324-11-0 |
Levetiracetam intermediates |
|
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4] triazolo[4,3-a] pyrazine hydrochloride |
|
762240-92-6 |
Sitagliptin intermediates |
(2,4,5-Trifluorophenyl) acetic acid |
|
209995-38-0 |
|
(R)-3-(tert-butoxy carbonyl)-4-(2,4,5-trifluorophenyl) butanoic acid |
|
486460-00-8 |
|
(2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester |
|
401564-36-1 |
Teneligliptin intermediates |
L-Prolinamide |
|
7531-52-4 |
Vildagliptin intermediates |
(2S)-N-(Chloroacetyl)-2-Pyrrolidine Carbonitrile |
|
207557-35-5 |
|
(R)-3-Amino-1-Butanol |
|
61477-40-5 |
Dolutegravir Intermediates |
3-(Benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid |
|
119736-16-2 |
Baloxavir intermediates |
7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-ol |
|
1985607-83-7 |
|
2,4,6-Trifluorobenzylamine |
|
214759-21-4 |
Bictegravir Intermediates |
(1R,3S)-3-Aminocyclopentanol |
|
1110772-05-8 |
|
((S)-3-Cyano-5-methyl hexanoic acid ethyl ester |
|
181289-39-4 |
Pregabalin intermediates |
(s)-3-methylamino-1-(thiophen-2yl) propan-1-ol |
|
116539-55-0 |
Duloxetine intermediates |
4-Bromomethyl-2-cyanobiphenyl |
|
114772-54-2 |
Olmesartan Intermediates |
5-(4'-Bromomethyl-1,1'-biphenyl-2-yl)-1-triphenyl methyl-1H-tetrazole |
|
124750-51-2 |
|
4-(1-hydroxy-1-methylethyl)-2-propyl-1H- Imidazole-5-carboxylic acid ethyl ester |
|
144689-93-0 |
|
4-Cloromethyl-5-methyl-1,3-dioxol-2-one |
|
80841-78-7 |
|
2-N-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl) benzimidazole |
|
152628-02-9 |
Telmisartan intermediates |
Methyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl) methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate |
|
139481-44-0 |
Candesartan/Azilsartan intermediates |
Ethyl-2-Ethoxy-1-[[(2'-Cyanobiphenyl-4-yl) Methyl] Benzimidazole]-7-Carboxylate |
|
139481-41-7 |
|
N-[(S)-1-Carbethoxy-1-butyl]-(S)-alanine |
|
82834-12-6 |
Perindoprilat Intermediates |
L-Octahydroindole-2-carboxylic acid |
|
80875-98-5 |
|
Cyclopropanamine,2-(3,4-difluorophenyl) -(1R,2S)-(2R,3R)-2,3-dihydroxybutanedioate (1:1) |
|
220352-39-6 |
Ticagrelor Intermediates |
4,6-dichloro-2-propylthiopyrimidine-5-amine |
|
145783-15-9 |
|
2-((3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyclopenta[d] [1,3] dioxol-4-yloxy) ethanol L-tartaric acid |
|
376608-65-0 |
|
4,5,6,7-tetrahydro-5-methyl-thiazolo[5,4-C] pyridine-2-carboxylic acid hydrochloride |
|
720720-96-7 |
Edoxaban intermediates |
4,5,6,7-tetrahydro-5-methyl-thiazolo[5,4-C] pyridine-2-carboxylic acid hydrochloride |
|
1243308-37-3 |
|
Tert-Butyl(1R,2S,5S)-2-azido-5-[(dimethylamine) carbonyl] cyclohexyl carbamate oxalic acid |
|
1353893-22-7 |
|
4-Chloro-6-ethyl-5-fluoropyrimidine |
|
137234-74-3 |
Voriconazole intermediates |
4-Ethyl-5-fluoro-6-hydroxypyrimidine |
|
137234-87-8 |
|
Methyl 2-methyl-2-(4-(2-(tosyloxy)ethyl) phenyl) propanoate |
|
1181267-30-0 |
Bilastine intermediates |
1-(2-ethoxyethyl)-2-(piperidin-4-yl)-1H-benzo[d]imidazole dihydrochloride |
|
1841081-72-8 |
|
(2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl) phenyl) tetrahydro-2H-pyran-3,4,5-triyl triacetate |
|
461432-25-7 |
Dapagliflozin intermediates |
(2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl) phenyl)-6-(hydroxyMethyl)-2-Methoxytetrahydro-2H-pyran-3,4,5-triol |
|
714269-57-5 |
|
(2-Chloro-5-iodophenyl) [4-[[(3S)-tetrahydro-3-furanyl] oxy] phenyl] methanone |
|
915095-87-3
|
Empagliflozin Intermediates |
(R)-(-)-3-Hydroxytetrahydrofuran |
|
86087-24-3 |
|
(1S)-1,5-anhydro-2,3,4,6-tetra-O-acteyl-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydrofu-ran-3-yl] oxy] phenyl] methyl] phenyl]-D-Glucitol |
|
915095-99-7 |
|
(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl] methyl]-4-methylphenyl]-D-glucitol 2,3,4,6-tetrakis(2,2-dimethylpropanoate) |
|
1283129-18-9 |
Canagliflozin Intermediates |
(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl] methyl]-4-methylphenyl]-D-glucitol tetraacetate |
|
866607-35-4 |
|
2-(5-bromo-2-methylbenzyl)-5-(4-fluorophenyl) thiophene |
|
1030825-20-7 |
|
α-L-Xylofuranose, 1,2-O-(1-methyl ethylidene)- |
|
114861-22-2 |
Sotagliflozin Intermediates |
(3aS,5R,6S,6aS)-6-Hydroxy-2,2-dimethyl-tetrahydro-2H-furo[2,3-d] [1,3] dioxole-5-carboxylic acid |
|
1103738-17-5 |
|
(2S,3S,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl) phenyl]-6-(methylthio) tetrahydropyran-3,4,5-triyl Triacetate |
|
1018899-03-0 |
|
(4-chloro-3-(4-ethoxybenzyl) phenyl) ((3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro [2,3-d] [1,3] dioxol-5-yl) Methanone |
|
1103738-30-2 |
|
(2S,3R,4S,5S)-2-(4-chloro-3-(4-ethoxybenzyl) phenyl)-6,6-bis(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol |
|
1528636-39-6 |
Ertugliflozin Intermediates |
(1R,2S,3S,4R,5S)-1-(acetoxymethyl)-5-(4-chloro-3-(4-ethoxybenzyl) phenyl)-6,8-dioxabicyclo [3.2.1] octane-2,3,4-triyltriacetate |
|
1298086-18-6 |
|
2,3-dimethyl-2H-indazol-6-amine hydrochloride |
|
635702-60-2 |
Pazopanib intermediates |
3-Amino-6-methylbenzenesulfonamide |
|
6973-09-7 |
|
2-(4-ethyl-3-iodophenyl)-2-Methylpropanoic acid |
|
1256584-73-2 |
Alectinib intermediates |
Tert-butyl 6-cyano-2-(2-(4-ethyl-3-iodophenyl) propan-2-yl)-1H-indole-3-carboxylate |
|
1256584-75-4 |
|
[2-Methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl] amine |
|
761440-75-9 |
Brigatinib intermediates |
2,5-Dichloro-N-(2-(Dimethylphosphoryl) Phenyl) Pyrimidin-4-Amine |
|
1197953-49-3 |
|
N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine dihydrochloride |
|
1260590-51-9 |
Tofacitinib intermediates |
CIS-N-BENZYL-3-METHYLAMINO-4-METHYL-PIPERIDINE BIS-(HYDROCHLORIDE) |
|
1062580-52-2 |